Simplex Trading’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Simplex Trading’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-8	Closed	-$21K	–	7145
2017 Q3	$21K	Buy	8 +4	+100%	+$57	﹤0.01%	3129
2017 Q2	$3K	Sell	4 -1	-20%	-$21	﹤0.01%	5121
2017 Q1	$2K	Sell	5 -9	-64%	-$232	﹤0.01%	5449
2016 Q4	$5K	Buy	+14	New	+$391	﹤0.01%	4450
2016 Q1	–	Sell	-5	Closed	-$14K	–	6672
2015 Q4	$14K	Hold	5	–	–	﹤0.01%	3037
2015 Q3	$15K	Buy	+5	New	+$131	﹤0.01%	3091
2015 Q2	–	Sell	-1	Closed	-$2K	–	6195
2015 Q1	$2K	Buy	+1	New	+$24	﹤0.01%	4270

Other funds holding IPCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Simplex Trading's IPCI Position: Q3 2018 in Review

Simplex Trading sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 120 shares.

Simplex Trading first reported a position in IPCI in Q4 2014 and held it in 8 quarters. The position peaked at $20K in Q3 2016. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

Simplex Trading reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
Simplex Trading sold 120 Intellipharmaceuticals International Inc. shares in Q3 2018.
Simplex Trading first reported a position in Intellipharmaceuticals International Inc. in Q4 2014 and held it in 8 quarters.
Simplex Trading's Intellipharmaceuticals International Inc. position peaked at $20K in Q3 2016.
10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.